- Home
- ZGN vs LGND Comparison
ZGN vs LGND Comparison
Compare ZGN & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZGN
- LGND
- Stock Information
- Founded
- ZGN 1910
- LGND 1987
- Country
- ZGN Italy
- LGND United States
- Employees
- ZGN N/A
- LGND N/A
- Industry
- ZGN Apparel
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- ZGN Consumer Discretionary
- LGND Health Care
- Exchange
- ZGN Nasdaq
- LGND Nasdaq
- Market Cap
- ZGN 2.0B
- LGND 2.3B
- IPO Year
- ZGN N/A
- LGND 1992
- Fundamental
- Price
- ZGN $8.40
- LGND $119.93
- Analyst Decision
- ZGN Buy
- LGND Strong Buy
- Analyst Count
- ZGN 2
- LGND 6
- Target Price
- ZGN $12.95
- LGND $144.83
- AVG Volume (30 Days)
- ZGN 1.3M
- LGND 137.1K
- Earning Date
- ZGN 09-18-2024
- LGND 11-07-2024
- Dividend Yield
- ZGN 1.55%
- LGND N/A
- EPS Growth
- ZGN 14.68
- LGND 160.46
- EPS
- ZGN 0.42
- LGND 2.47
- Revenue
- ZGN $2,101,802,207.00
- LGND $152,422,000.00
- Revenue This Year
- ZGN $1.07
- LGND $26.86
- Revenue Next Year
- ZGN $3.69
- LGND $13.16
- P/E Ratio
- ZGN $20.17
- LGND $48.52
- Revenue Growth
- ZGN 17.68
- LGND N/A
- 52 Week Low
- ZGN $7.13
- LGND $58.97
- 52 Week High
- ZGN $15.26
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- ZGN 61.87
- LGND 55.34
- Support Level
- ZGN $7.75
- LGND $119.18
- Resistance Level
- ZGN $8.31
- LGND $125.00
- Average True Range (ATR)
- ZGN 0.37
- LGND 4.56
- MACD
- ZGN 0.14
- LGND 0.07
- Stochastic Oscillator
- ZGN 92.31
- LGND 64.28
About ZGN Ermenegildo Zegna N.V.
Ermenegildo Zegna NV designs creates, and distributes luxury menswear and accessories under the Zegna brand, as well as womenswear, menswear, and accessories under the Thom Browne brand. It operates in three segments: the Zegna segment (comprising three product lines: Zegna Branded Products, Textile, and Third Party Brands); the Thom Browne segment; and the Tom Ford Fashion segment. It generates the majority of its revenue from the Zegna segment.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.